VVOS
HEALTHCAREVivos Therapeutics Inc
$0.72+0.01 (+1.47%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving VVOS Today?
No stock-specific AI insight has been generated for VVOS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.65$7.95
$0.72
Fundamentals
Market Cap$10M
P/E Ratio—
EPS$-2.07
Dividend Yield—
Dividend / Share—
ROE-6.6%
Profit Margin-1.2%
Debt / Equity—
Trading
Volume152K
Avg Volume (10D)—
Shares Outstanding13.6M
VVOS News
20 articles- New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)Yahoo Finance·Apr 18, 2026
- Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...Yahoo Finance·Apr 16, 2026
- Vivos Therapeutics Reports Full Year 2025 Financial ResultsYahoo Finance·Apr 15, 2026
- Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference CallYahoo Finance·Apr 15, 2026
- Vivos Therapeutics, Inc. Q4 2025 Earnings Call SummaryMoby·Apr 15, 2026
- New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)Yahoo Finance·Apr 11, 2026
- New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)Yahoo Finance·Apr 11, 2026
- Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca PartnersYahoo Finance·Apr 7, 2026
- New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)Yahoo Finance·Mar 28, 2026
- Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada MarketYahoo Finance·Mar 26, 2026
- NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings EstimatesYahoo Finance·Mar 23, 2026
- Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag EstimatesYahoo Finance·Mar 19, 2026
- Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral AnatomyYahoo Finance·Mar 17, 2026
- Health Catalyst (HCAT) Lags Q4 Earnings EstimatesYahoo Finance·Mar 12, 2026
- Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss EstimatesYahoo Finance·Mar 3, 2026
- New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM ESTYahoo Finance·Feb 28, 2026
- New to The Street and Wall Street New York Magazine Launch Weekly Executive Publication with Integrated NewsOut Video Press DistributionYahoo Finance·Feb 24, 2026
- New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin AmericaYahoo Finance·Feb 21, 2026
- New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)Yahoo Finance·Feb 14, 2026
- Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep TechnologiesYahoo Finance·Feb 5, 2026
All 20 articles loaded
Price Data
Open$0.70
Previous Close$0.71
Day High$0.74
Day Low$0.70
52 Week High$7.95
52 Week Low$0.65
52-Week Range
$0.65$7.95
$0.72
Fundamentals
Market Cap$10M
P/E Ratio—
EPS$-2.07
Dividend Yield—
Dividend / Share—
ROE-6.6%
Profit Margin-1.2%
Debt / Equity—
Trading
Volume152K
Avg Volume (10D)—
Shares Outstanding13.6M
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—